drugset / Trial / NCT00419653

Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy

NCT00419653

Phase 4 Terminated 19 enrolled University of Jena Sanofi · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims to investigate the modulation of regional brain activation in schizophrenic patients by psychopharmacological treatment with either haloperidol, amisulpride or olanzapine. The study will be performed with functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI).

Timeline

Start
2003-01
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule
Comparator Haloperidol Other / unclassified
Comparator Olanzapine Small molecule

Indications